Source comparison
CJC-1295 Blood Work Labs Monitor: Comparison of Testing Protocols
This table compares three common CJC-1295 blood work labs monitor approaches. Minimal, standard, and comprehensive. Showing what each protocol tracks, when labs are drawn, and what each protocol misses. Minimal (IGF-1 Only) IGF-1 Baseline + Week 6 Confirms pit
This comparison does not assign a generated winner or score.
- This table compares three common CJC-1295 blood work labs monitor approaches. Minimal, standard, and comprehensive. Showing what each protocol tracks, when labs are drawn, and what each protocol misses.
- Minimal (IGF-1 Only)
- IGF-1
- Baseline + Week 6
- Confirms pituitary response to CJC-1295
- Glucose dysregulation, liver stress, lipid changes, prolactin elevation
- Confirms efficacy but provides no safety data. High risk for undetected metabolic side effects
- Standard (IGF-1 + Metabolic)
- IGF-1, fasting glucose, HbA1c, lipid panel
- Baseline + Week 6 + Week 12
- Efficacy + glucose/lipid shifts over 12 weeks
- Liver enzyme elevation, prolactin issues, thyroid suppression
- Balances safety and cost. Appropriate for healthy subjects with no metabolic risk factors
- Comprehensive (Full Panel)
- IGF-1, glucose, HbA1c, lipids, AST/ALT, prolactin, TSH/T3/T4
- Baseline + Week 6 + Week 12 + Every 12 weeks
- Full metabolic, hepatic, endocrine picture throughout protocol
- Nothing. Captures all clinically relevant pathways affected by GH elevation
- Gold standard for research protocols. Especially critical for subjects over 40 or those with pre-existing metabolic conditions